MedPath

Efficacy Study of the Medical Device TRP Snorless™ in the Treatment of Snoring

Not Applicable
Conditions
Snoring
Interventions
Device: TRP
Registration Number
NCT03222193
Lead Sponsor
Tongue Laboratory
Brief Summary

The Tongue Right Positioner (TRP Snorless™) is a medical device designed to restore physiological tongue positions when functioning or at rest and increase tongue muscles tone. Patient wears TRP Snorless™ daily at least 5 hours during night. Published data suggested that TRP Snorless™ increases oropharynx diameter and nasal patency, favouring airflow in upper airways. Independently of patient's adherence to daily myofascial exercises, the TRP Snorless™ treatment should increase tongue muscles' tone and decrease the risk of snoring during sleep.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
35
Inclusion Criteria
  • Man or woman ≥ 18 years and ≤ 65 years at the time of signing informed consent
  • Listed as continuous snorer (snoring at least 4 nights/week)
  • Answer "Extremely loud" or "very loud" to question 1 of SBPS at screening
  • Answer "very severe" or "severe" to question 2 of SBPS at screening
  • Answer "extremely" or "quite a bit" to question 3 of SBPS at screening
  • Dated and signed informed consent
  • BMI ≤ 35
Exclusion Criteria
  • Severe Mandibular retrognathia and micrognathia
  • Narrow and deep palate (less than 3 cm wide)
  • Lack of three consecutive teeth in the area of (15-16-17-18) or (25-26-27-28).
  • Lingual or labial short frenulum (the tongue cannot reach the upper incisors when mouth can be opened for two fingers)
  • Intolerable gag reflex
  • Known nasal septal deviation
  • Neck circumference > 46 cm
  • Patient currently treated for OSA
  • Patient with AHI≥30 events/hour or with AHI>15 and (SFI) Sleep Fragmentation Index > 20
  • Patient currently treated for central sleep apnoea
  • Addiction to alcoholic beverages (5 drinks per day per NIAAA)
  • Under constant pharmacological treatment for depression, anxiety, chronic pain, insomnia
  • Hypertrophy of tonsils
  • Macroglossia
  • Hypertrophy of uvula
  • Primary gastroesophageal reflux
  • Any other pathology preventing subject from complying with the protocol
  • Subject with recent oropharyngeal surgery or likely during the study
  • Mental inability, unwillingness or language barrier precluding adequate understanding of or compliance with study procedures
  • Pregnancy
  • Patient with severe Chronic Obstructive Pulmonary Disease
  • Asthmatic patient under inhaled corticoid therapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
TRP groupTRPSnoring subjects treated with the Tongue Right Positioner (TRP) medical device
Primary Outcome Measures
NameTimeMethod
Snore Index3 months

number of snores \>36 dB per hour of sleep by BresoDx

Secondary Outcome Measures
NameTimeMethod
Sleep time3 months

Total sleep time (h), in supine, non-supine and both positions by BresoDx

Orofacial functional score (NOT-S questionnaire)3 months

Using NOT-S questionnaire

Tongue Endurance score3 months

Using IOPI medical device

Quality of sleep3 months

Using Spiegel questionnaire

Comfort / Safety3 months

Using homemade questionnaire relative to TRP snorless TM

Treatment compliance3 months

Using the The TheraMon® temperature micro sensor

Mean sound of snoring/night3 months

(dB), in supine, non-supine and both positions by BresoDx

Maximum sound of snoring/night3 months

(dB), in supine, non-supine and both positions by BresoDx

Nasal patency3 months

Measure of the Peak Nasal Inspiratory Flow by In-check PNIF meter

Apnoea Hypopnea Index3 months

(AHI) Number of apnea/hypopnea per hour of sleep, in supine, non-supine and both positions by BresoDx

Trial Locations

Locations (1)

Poliklinika Šustova 1930/2

🇨🇿

Praha 4, Czechia

© Copyright 2025. All Rights Reserved by MedPath